{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T01:52:38Z","timestamp":1784166758300,"version":"3.55.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T00:00:00Z","timestamp":1713830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T00:00:00Z","timestamp":1713830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Bladder cancer (BC) is the ninth most-common cancer worldwide and it is associated with high morbidity and mortality. Mitochondrial Dysfunction is involved in the progression of BC. This study aimed to developed a novel diagnostic model based on mitochondria-related genes (MRGs) for BC patients using Machine Learning. In this study, we analyzed GSE13507 datasets and identified 752 DE-MRGs in BC specimens. Functional enrichment analysis uncovered the significant roles of 752 DE-MRGs in key processes such as cellular and organ development, as well as gene regulation. The analysis revealed the crucial functions of these genes in transcriptional regulation and protein-DNA interactions. Then, we performed LASSO and SVM-RFE, and identified four critical diagnostic genes including GLRX2, NMT1, OXSM and TRAF3IP3. Based on the above four genes, we developed a novel diagnostic model whose diagnostic value was confirmed in GSE13507, GSE3167 and GSE37816 datasets. Moreover, we reported the expressing pattern of GLRX2, NMT1, OXSM and TRAF3IP3 in BC samples. Immune cell infiltration analysis revealed that the four genes were associated with several immune cells. Finally, we performed RT-PCR and confirmed NMT1 was highly expressed in BC cells. Functional experiments revealed that knockdown of NMT1 suppressed the proliferation of BC cells. Overall, we have formulated a diagnostic potential that offered a comprehensive framework for delving into the underlying mechanisms of BC. Before proceeding with clinical implementation, it is essential to undertake further investigative efforts to validate its diagnostic effectiveness in BC patients.<\/jats:p>","DOI":"10.1038\/s41598-024-60068-9","type":"journal-article","created":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T06:02:16Z","timestamp":1713852136000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Machine-learning prediction of a novel diagnostic model using mitochondria-related genes for patients with bladder cancer"],"prefix":"10.1038","volume":"14","author":[{"given":"Jian","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,23]]},"reference":[{"key":"60068_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel, R. L., Miller, K. D., Fuchs, H. E. & Jemal, A. Cancer Statistics, 2021. CA Cancer J. Clin. 71, 7\u201333 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"60068_CR2","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1001\/jama.2020.17598","volume":"324","author":"AT Lenis","year":"2020","unstructured":"Lenis, A. T., Lec, P. M., Chamie, K. & Mshs, M. D. Bladder Cancer: A Review. Jama 324, 1980\u20131991 (2020).","journal-title":"Jama"},{"key":"60068_CR3","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.eururo.2015.08.037","volume":"69","author":"J Dobruch","year":"2016","unstructured":"Dobruch, J. et al. Gender and bladder cancer: A collaborative review of etiology, biology, and outcomes. Eur. Urol. 69, 300\u2013310 (2016).","journal-title":"Eur. Urol."},{"key":"60068_CR4","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s11934-018-0860-6","volume":"19","author":"SK Bhanvadia","year":"2018","unstructured":"Bhanvadia, S. K. Bladder cancer survivorship. Curr. Urol. Rep. 19, 111 (2018).","journal-title":"Curr. Urol. Rep."},{"key":"60068_CR5","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.plipres.2013.07.002","volume":"52","author":"SE Horvath","year":"2013","unstructured":"Horvath, S. E. & Daum, G. Lipids of mitochondria. Prog. Lipid Res. 52, 590\u2013614 (2013).","journal-title":"Prog. Lipid Res."},{"key":"60068_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2019.100940","volume":"54","author":"M Akbari","year":"2019","unstructured":"Akbari, M., Kirkwood, T. B. L. & Bohr, V. A. Mitochondria in the signaling pathways that control longevity and health span. Ageing Res. Rev. 54, 100940 (2019).","journal-title":"Ageing Res. Rev."},{"key":"60068_CR7","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41467-019-13668-3","volume":"11","author":"I Mart\u00ednez-Reyes","year":"2020","unstructured":"Mart\u00ednez-Reyes, I. & Chandel, N. S. Mitochondrial TCA cycle metabolites control physiology and disease. Nat. Commun. 11, 102 (2020).","journal-title":"Nat. Commun."},{"key":"60068_CR8","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/nchembio.2287","volume":"13","author":"ND Georgakopoulos","year":"2017","unstructured":"Georgakopoulos, N. D., Wells, G. & Campanella, M. The pharmacological regulation of cellular mitophagy. Nat. Chem. Biol. 13, 136\u2013146 (2017).","journal-title":"Nat. Chem. Biol."},{"key":"60068_CR9","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1111\/brv.12291","volume":"92","author":"RE Koch","year":"2017","unstructured":"Koch, R. E., Josefson, C. C. & Hill, G. E. Mitochondrial function, ornamentation, and immunocompetence. Biol. Rev. Camb. Philos. Soc. 92, 1459\u20131474 (2017).","journal-title":"Biol. Rev. Camb. Philos. Soc."},{"key":"60068_CR10","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.ccr.2008.05.005","volume":"13","author":"G Kroemer","year":"2008","unstructured":"Kroemer, G. & Pouyssegur, J. Tumor cell metabolism: cancer\u2019s Achilles\u2019 heel. Cancer Cell 13, 472\u2013482 (2008).","journal-title":"Cancer Cell"},{"key":"60068_CR11","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/cr.2017.155","volume":"28","author":"PE Porporato","year":"2018","unstructured":"Porporato, P. E., Filigheddu, N., Pedro, J. M. B., Kroemer, G. & Galluzzi, L. Mitochondrial metabolism and cancer. Cell Res. 28, 265\u2013280 (2018).","journal-title":"Cell Res."},{"key":"60068_CR12","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.cmet.2020.06.019","volume":"32","author":"K Vasan","year":"2020","unstructured":"Vasan, K., Werner, M. & Chandel, N. S. Mitochondrial metabolism as a target for cancer therapy. Cell Metab. 32, 341\u2013352 (2020).","journal-title":"Cell Metab."},{"key":"60068_CR13","doi-asserted-by":"publisher","first-page":"164","DOI":"10.2174\/1871520616666161031143301","volume":"17","author":"L Schwartz","year":"2017","unstructured":"Schwartz, L., Supuran, C. T. & Alfarouk, K. O. The warburg effect and the Hallmarks of Cancer. Anticancer Agents Med. Chem. 17, 164\u2013170 (2017).","journal-title":"Anticancer Agents Med. Chem."},{"key":"60068_CR14","doi-asserted-by":"crossref","unstructured":"Oresta, B., Pozzi, C., Braga, D., Hurle, R., Lazzeri, M., Colombo, P., Frego, N., Erreni, M., Faccani, C., Elefante, G., Barcella, M., Guazzoni, G., and Rescigno, M. Mitochondrial metabolic reprogramming controls the induction of immunogenic cell death and efficacy of chemotherapy in bladder cancer. Sci. Transl. Med. 13 (2021).","DOI":"10.1126\/scitranslmed.aba6110"},{"key":"60068_CR15","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.critrevonc.2017.07.001","volume":"117","author":"A Cormio","year":"2017","unstructured":"Cormio, A. et al. Mitochondrial dysfunctions in bladder cancer: Exploring their role as disease markers and potential therapeutic targets. Crit. Rev. Oncol. Hematol. 117, 67\u201372 (2017).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"60068_CR16","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.urolonc.2018.04.010","volume":"36","author":"BL Woolbright","year":"2018","unstructured":"Woolbright, B. L., Ayres, M. & Taylor, J. A. 3rd. Metabolic changes in bladder cancer. Urol. Oncol. 36, 327\u2013337 (2018).","journal-title":"Urol. Oncol."},{"key":"60068_CR17","doi-asserted-by":"crossref","unstructured":"Reznik, E., Miller, M.L., \u015eenbabao\u011flu, Y., Riaz, N., Sarungbam, J., Tickoo, S.K., Al-Ahmadie, H.A., Lee, W., Seshan, V.E., Hakimi, A.A., and Sander, C. Mitochondrial DNA copy number variation across human cancers. Elife 5 (2016).","DOI":"10.7554\/eLife.10769"},{"key":"60068_CR18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41580-021-00407-0","volume":"23","author":"JG Greener","year":"2022","unstructured":"Greener, J. G., Kandathil, S. M., Moffat, L. & Jones, D. T. A guide to machine learning for biologists. Nat. Rev. Mol. Cell Biol. 23, 40\u201355 (2022).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"60068_CR19","first-page":"14","volume":"9","author":"RY Choi","year":"2020","unstructured":"Choi, R. Y., Coyner, A. S., Kalpathy-Cramer, J., Chiang, M. F. & Campbell, J. P. Introduction to machine learning, neural networks, and deep learning. Transl. Vis. Sci. Technol. 9, 14 (2020).","journal-title":"Transl. Vis. Sci. Technol."},{"key":"60068_CR20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13148-020-00842-4","volume":"12","author":"S Rauschert","year":"2020","unstructured":"Rauschert, S., Raubenheimer, K., Melton, P. E. & Huang, R. C. Machine learning and clinical epigenetics: a review of challenges for diagnosis and classification. Clin. Epigenetics 12, 51 (2020).","journal-title":"Clin. Epigenetics"},{"key":"60068_CR21","doi-asserted-by":"publisher","DOI":"10.2196\/12286","volume":"21","author":"AK Triantafyllidis","year":"2019","unstructured":"Triantafyllidis, A. K. & Tsanas, A. Applications of machine learning in real-life digital health interventions: Review of the literature. J. Med. Internet Res. 21, e12286 (2019).","journal-title":"J. Med. Internet Res."},{"key":"60068_CR22","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.semcancer.2019.12.011","volume":"68","author":"NT Issa","year":"2021","unstructured":"Issa, N. T., Stathias, V., Sch\u00fcrer, S. & Dakshanamurthy, S. Machine and deep learning approaches for cancer drug repurposing. Semin. Cancer Biol. 68, 132\u2013142 (2021).","journal-title":"Semin. Cancer Biol."},{"key":"60068_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1476-4598-9-3","volume":"9","author":"WJ Kim","year":"2010","unstructured":"Kim, W. J. et al. Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer. Mol. Cancer 9, 3 (2010).","journal-title":"Mol. Cancer"},{"key":"60068_CR24","doi-asserted-by":"publisher","first-page":"4040","DOI":"10.1158\/0008-5472.CAN-03-3620","volume":"64","author":"L Dyrskj\u00f8t","year":"2004","unstructured":"Dyrskj\u00f8t, L. et al. Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification. Cancer Res. 64, 4040\u20134048 (2004).","journal-title":"Cancer Res."},{"key":"60068_CR25","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1002\/ijc.28121","volume":"133","author":"YJ Kim","year":"2013","unstructured":"Kim, Y. J. et al. HOXA9, ISL1 and ALDH1A3 methylation patterns as prognostic markers for nonmuscle invasive bladder cancer: array-based DNA methylation and expression profiling. Int. J. Cancer 133, 1135\u20131142 (2013).","journal-title":"Int. J. Cancer"},{"key":"60068_CR26","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Kawashima, M. & Ishiguro-Watanabe, M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51, D587-d592 (2023).","journal-title":"Nucleic Acids Res."},{"key":"60068_CR27","doi-asserted-by":"publisher","first-page":"7253","DOI":"10.1109\/TPAMI.2021.3092177","volume":"44","author":"H Wang","year":"2022","unstructured":"Wang, H., Shao, Y., Zhou, S., Zhang, C. & Xiu, N. Support vector machine classifier via L(0\/1) soft-margin loss. IEEE Trans. Pattern Anal. Mach. Intell. 44, 7253\u20137265 (2022).","journal-title":"IEEE Trans. Pattern Anal. Mach. Intell."},{"key":"60068_CR28","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/nm.3909","volume":"21","author":"AJ Gentles","year":"2015","unstructured":"Gentles, A. J. et al. The prognostic landscape of genes and infiltrating immune cells across human cancers. Nat. Med. 21, 938\u2013945 (2015).","journal-title":"Nat. Med."},{"key":"60068_CR29","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3322\/caac.21631","volume":"70","author":"VG Patel","year":"2020","unstructured":"Patel, V. G., Oh, W. K. & Galsky, M. D. Treatment of muscle-invasive and advanced bladder cancer in 2020. CA Cancer J. Clin. 70, 404\u2013423 (2020).","journal-title":"CA Cancer J. Clin."},{"key":"60068_CR30","doi-asserted-by":"publisher","first-page":"13986","DOI":"10.1080\/21655979.2022.2085284","volume":"13","author":"X Sun","year":"2022","unstructured":"Sun, X., Xin, S., Jin, L., Zhang, Y. & Ye, L. Neurexophilin 4 is a prognostic biomarker correlated with immune infiltration in bladder cancer. Bioengineered 13, 13986\u201313999 (2022).","journal-title":"Bioengineered"},{"key":"60068_CR31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.urolonc.2020.08.016","volume":"39","author":"K Ng","year":"2021","unstructured":"Ng, K., Stenzl, A., Sharma, A. & Vasdev, N. Urinary biomarkers in bladder cancer: A review of the current landscape and future directions. Urol. Oncol. 39, 41\u201351 (2021).","journal-title":"Urol. Oncol."},{"key":"60068_CR32","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.hoc.2021.02.004","volume":"35","author":"H Ahmadi","year":"2021","unstructured":"Ahmadi, H., Duddalwar, V. & Daneshmand, S. Diagnosis and staging of bladder cancer. Hematol. Oncol. Clin. North Am. 35, 531\u2013541 (2021).","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"60068_CR33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41585-018-0105-y","volume":"16","author":"B Jordan","year":"2019","unstructured":"Jordan, B. & Meeks, J. J. T1 bladder cancer: Current considerations for diagnosis and management. Nat. Rev. Urol. 16, 23\u201334 (2019).","journal-title":"Nat. Rev. Urol."},{"key":"60068_CR34","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.cell.2012.02.035","volume":"148","author":"J Nunnari","year":"2012","unstructured":"Nunnari, J. & Suomalainen, A. Mitochondria: In sickness and in health. Cell 148, 1145\u20131159 (2012).","journal-title":"Cell"},{"key":"60068_CR35","doi-asserted-by":"crossref","unstructured":"Andrieux, P., Chevillard, C., Cunha-Neto, E., and Nunes, J.P.S. Mitochondria as a Cellular Hub in Infection and Inflammation. Int. J. Mol. Sci. 22 (2021).","DOI":"10.3390\/ijms222111338"},{"key":"60068_CR36","doi-asserted-by":"publisher","first-page":"112728","DOI":"10.1016\/j.celrep.2023.112728","volume":"42","author":"Z Al Amir Dache","year":"2023","unstructured":"Al Amir Dache, Z. & Thierry, A. R. Mitochondria-derived cell-to-cell communication. Cell Rep. 42, 112728 (2023).","journal-title":"Cell Rep."},{"key":"60068_CR37","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.cmi.2019.09.009","volume":"26","author":"N Peiffer-Smadja","year":"2020","unstructured":"Peiffer-Smadja, N. et al. Machine learning for clinical decision support in infectious diseases: a narrative review of current applications. Clin. Microbiol. Infect. 26, 584\u2013595 (2020).","journal-title":"Clin. Microbiol. Infect."},{"key":"60068_CR38","doi-asserted-by":"publisher","first-page":"29s","DOI":"10.2967\/jnumed.118.220590","volume":"60","author":"F Nensa","year":"2019","unstructured":"Nensa, F., Demircioglu, A. & Rischpler, C. Artificial intelligence in nuclear medicine. J. Nucl. Med. 60, 29s\u201337s (2019).","journal-title":"J. Nucl. Med."},{"key":"60068_CR39","doi-asserted-by":"crossref","unstructured":"Liao, Y., Han, L., Wang, H., and Zhang, H. Prediction models for railway track geometry degradation using machine learning methods: A review. Sensors (Basel) 22 (2022).","DOI":"10.3390\/s22197275"},{"key":"60068_CR40","first-page":"41","volume":"15","author":"S Huang","year":"2018","unstructured":"Huang, S. et al. Applications of support vector machine (SVM) learning in cancer genomics. Cancer Genom. Proteom. 15, 41\u201351 (2018).","journal-title":"Cancer Genom. Proteom."},{"key":"60068_CR41","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.pbiomolbio.2022.07.004","volume":"174","author":"P Deepa","year":"2022","unstructured":"Deepa, P. & Gunavathi, C. A systematic review on machine learning and deep learning techniques in cancer survival prediction. Progr. Biophys. Mol. Biol. 174, 62\u201371 (2022).","journal-title":"Progr. Biophys. Mol. Biol."},{"issue":"9","key":"60068_CR42","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.3390\/antiox11091643","volume":"11","author":"J Li","year":"2022","unstructured":"Li, J. et al. Mitochondrial Glrx2 knockout augments acetaminophen-induced hepatotoxicity in mice. Antioxidants 11(9), 1643 (2022).","journal-title":"Antioxidants"},{"key":"60068_CR43","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.yjmcc.2007.08.021","volume":"44","author":"N Nagy","year":"2008","unstructured":"Nagy, N. et al. Overexpression of glutaredoxin-2 reduces myocardial cell death by preventing both apoptosis and necrosis. J. Mol. Cell Cardiol. 44, 252\u2013260 (2008).","journal-title":"J. Mol. Cell Cardiol."},{"key":"60068_CR44","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1095\/biolreprod.112.099952","volume":"87","author":"Y Yuan","year":"2012","unstructured":"Yuan, Y., Wheeler, M. B. & Krisher, R. L. Disrupted redox homeostasis and aberrant redox gene expression in porcine oocytes contribute to decreased developmental competence. Biol. Reprod. 87, 78 (2012).","journal-title":"Biol. Reprod."},{"key":"60068_CR45","doi-asserted-by":"publisher","first-page":"171","DOI":"10.5483\/BMBRep.2012.45.3.171","volume":"45","author":"JT Yeon","year":"2012","unstructured":"Yeon, J. T. et al. Glutaredoxin2 isoform b (Glrx2b) promotes RANKL-induced osteoclastogenesis through activation of the p38-MAPK signaling pathway. BMB Rep. 45, 171\u2013176 (2012).","journal-title":"BMB Rep."},{"key":"60068_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.914971","volume":"13","author":"H Li","year":"2022","unstructured":"Li, H. et al. TRAF3IP3 is cleaved by EV71 3C protease and exhibits antiviral activity. Front. Microbiol. 13, 914971 (2022).","journal-title":"Front. Microbiol."},{"key":"60068_CR47","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41423-019-0234-0","volume":"17","author":"X Zhang","year":"2020","unstructured":"Zhang, X. et al. TRAF3IP3 at the trans-Golgi network regulates NKT2 maturation via the MEK\/ERK signaling pathway. Cell Mol. Immunol. 17, 395\u2013406 (2020).","journal-title":"Cell Mol. Immunol."},{"key":"60068_CR48","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/cei.12658","volume":"182","author":"S Peng","year":"2015","unstructured":"Peng, S. et al. TRAF3IP3, a novel autophagy up-regulated gene, is involved in marginal zone B lymphocyte development and survival. Clin. Exp. Immunol. 182, 57\u201368 (2015).","journal-title":"Clin. Exp. Immunol."},{"key":"60068_CR49","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000031501","volume":"101","author":"W Li","year":"2022","unstructured":"Li, W. et al. The variants in PTPRB, TRAF3IP3, and DISC1 genes were associated with Graves\u2019 disease in the Chinese population. Medicine (Baltimore) 101, e31501 (2022).","journal-title":"Medicine (Baltimore)"},{"key":"60068_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.776834","volume":"12","author":"Q Lin","year":"2022","unstructured":"Lin, Q. et al. TRAF3IP3 promotes glioma progression through the ERK signaling pathway. Front. Oncol. 12, 776834 (2022).","journal-title":"Front. Oncol."},{"key":"60068_CR51","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41392-022-01248-9","volume":"8","author":"XP Tan","year":"2023","unstructured":"Tan, X. P. et al. Blockade of NMT1 enzymatic activity inhibits N-myristoylation of VILIP3 protein and suppresses liver cancer progression. Signal Transduct. Target Ther. 8, 14 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"60068_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2023.110739","volume":"109","author":"H Wang","year":"2023","unstructured":"Wang, H. et al. NMT1 sustains ICAM-1 to modulate adhesion and migration of tumor cells. Cell Signal 109, 110739 (2023).","journal-title":"Cell Signal"},{"key":"60068_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.681366","volume":"11","author":"G Zhu","year":"2021","unstructured":"Zhu, G. et al. N-Myristoylation by NMT1 Is POTEE-dependent to stimulate liver tumorigenesis via differentially regulating ubiquitination of targets. Front. Oncol. 11, 681366 (2021).","journal-title":"Front. Oncol."},{"key":"60068_CR54","doi-asserted-by":"publisher","first-page":"4864","DOI":"10.1021\/acs.jcim.3c00835","volume":"63","author":"A Kumar","year":"2023","unstructured":"Kumar, A. & Vashisth, H. Mechanism of ligand discrimination by the NMT1 riboswitch. J. Chem. Inf. Model. 63, 4864\u20134874 (2023).","journal-title":"J. Chem. Inf. Model."},{"key":"60068_CR55","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1038\/s41419-018-1201-x","volume":"9","author":"L Deng","year":"2018","unstructured":"Deng, L. et al. NMT1 inhibition modulates breast cancer progression through stress-triggered JNK pathway. Cell Death Dis. 9, 1143 (2018).","journal-title":"Cell Death Dis."},{"key":"60068_CR56","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.canlet.2022.01.001","volume":"529","author":"Y Sun","year":"2022","unstructured":"Sun, Y. et al. N-myristoyltransferase-1 deficiency blocks myristoylation of LAMTOR1 and inhibits bladder cancer progression. Cancer Lett. 529, 126\u2013138 (2022).","journal-title":"Cancer Lett."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-60068-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-60068-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-60068-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T06:05:36Z","timestamp":1713852336000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-60068-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,23]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["60068"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-60068-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,23]]},"assertion":[{"value":"22 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9282"}}